Romeo, G.; Ciaffaglione, V.; Amata, E.; Dichiara, M.; Calabrese, L.; Vanella, L.; Sorrenti, V.; Grosso, S.; D’Amico, A.G.; D’Agata, V.;
et al. Combination of Heme Oxygenase-1 Inhibition and Sigma Receptor Modulation for Anticancer Activity. Molecules 2021, 26, 3860.
https://doi.org/10.3390/molecules26133860
AMA Style
Romeo G, Ciaffaglione V, Amata E, Dichiara M, Calabrese L, Vanella L, Sorrenti V, Grosso S, D’Amico AG, D’Agata V,
et al. Combination of Heme Oxygenase-1 Inhibition and Sigma Receptor Modulation for Anticancer Activity. Molecules. 2021; 26(13):3860.
https://doi.org/10.3390/molecules26133860
Chicago/Turabian Style
Romeo, Giuseppe, Valeria Ciaffaglione, Emanuele Amata, Maria Dichiara, Loredana Calabrese, Luca Vanella, Valeria Sorrenti, Salvo Grosso, Agata Grazia D’Amico, Velia D’Agata,
and et al. 2021. "Combination of Heme Oxygenase-1 Inhibition and Sigma Receptor Modulation for Anticancer Activity" Molecules 26, no. 13: 3860.
https://doi.org/10.3390/molecules26133860
APA Style
Romeo, G., Ciaffaglione, V., Amata, E., Dichiara, M., Calabrese, L., Vanella, L., Sorrenti, V., Grosso, S., D’Amico, A. G., D’Agata, V., Intagliata, S., & Salerno, L.
(2021). Combination of Heme Oxygenase-1 Inhibition and Sigma Receptor Modulation for Anticancer Activity. Molecules, 26(13), 3860.
https://doi.org/10.3390/molecules26133860